Nu-Life Solutions SEZC is the global developer and provider of Nu-V3 and the Nu-V3 program.

Nu-V3 is a miniaturized, wearable, non-invasive, non-pharmaceutical technology for the treatment of pain, anxiety, depression and sleeplessness and is patented and trademarked in more than 40 countries including the United States, Europe, Japan and Latin America.

The symptoms of pain, anxiety, depression and sleeplessness affect more than 1.2 billion people worldwide today, with more than 40% actively seeking treatment.

There is a well known over reliance on addictive medications that have reached epic proportions. Nu-Life intends to serve as an answer on a global scale, beginning with Nu-Life USA, Nu-Life Europe and Nu-Life Japan leading the way.

Until now, there is never been a truly effective and safe alternative to treat those suffering from pain, anxiety, depression, and sleeplessness.